T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group
暂无分享，去创建一个
A. Rosenwald | R. Greil | H. Eich | W. Klapper | M. Hallek | J. Dierlamm | A. Hüttmann | A. Fosså | C. Kobe | J. Zijlstra | F. Keil | P. Borchmann | B. Hertenstein | A. Engert | M. Fuchs | U. Novak | S. Mathas | J. Hellmuth | A. Viardot | Gundolf Schneider | J. Meissner | M. Hänel | A. Moccia | C. Baues | S. Kreissl | M. Herzberg | V. Schaub | Volker Diehl | S. Martín | Pratush Giri | V. Diehl